CURX

Conviction 0HealthcareScan · Thu, Jun 25, 2026

CURX$0.2630-0.75%

ResistanceSupportVol 14

Vol MA14 100.72K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Curanex Pharmaceuticals IncPHARMACEUTICAL PREPARATIONSwww.curanexpharma.com ↗

Price0.2630

Change-0.75%

Gap+0.26%

Rel volume0.78×

Avg volume88.38K

Avg $ vol27.63K

SMA 200.3127

SMA 500.3500

SMA 2000.6991

Price vs 50-24.85%

Price vs 200-62.38%

MA stackbearish

50/200 cross—

Supertrenddown · 0.3490

RSI (14)34

MACD hist-0.00

MACD crossbear · 3d

Stoch %K / %D0 / 1

ADX (14)15

+DI / −DI13 / 18

RSI divergence—

MACD divergence—

ATR %+11.10%

ADR %9.14%

52w high9.16

52w low0.2630

From 52w high-97.13%

Above 52w low+0.00%

New 52w highNo

SqueezeOff

Bollinger width33.46%

%B0.03

Donchian pos0.00%

Donchian high0.3699

Donchian low0.2630

AVWAP (52w high)0.8840

vs AVWAP high-70.25%

AVWAP (52w low)0.4876

vs AVWAP low-46.07%

OBV trendFlat

Chaikin MF (20)-0.31

Today vs 20d0.78×

Avg vol (14d)100.72K

Avg vol (20d)88.38K

Avg $ vol (20d)27.63K

Market cap7.46M

RS 3m (vs SPY)-60.55%

RS 6m (vs SPY)-37.05%

RS line new highNo

Trend template—

Technical rank7.1

1 week-21.49%

1 month-19.94%

3 months-49.23%

6 months-32.60%

1 year—

YTD-28.59%

P/E-1.77

P/B0.92

P/S—

P/FCF—

EPS-0.1700

Div yield—

ROE-52.30%

ROA-50.23%

Debt/Eq—

Current62.87

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-1068.75%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value3.46M

Revenue—

Net income-3.15M

Gross profit—

Free cash flow—

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out28.36M

Employees6

ListedTue, Aug 26, 2025

Free float9.11M

Float %32.2%

Short interest25.44K

Days to cover0.5d

Short volume7.0%

Squeeze score3 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank7.1 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.3849

Support0.3000

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CURX

All disclosures →

No recent disclosed trades by Congress in CURX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CURX

No recent insider (Form 4) filings in CURX. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in CURX

EDGAR →

No recent SEC filings on file for CURX.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.